GENSPEED multiplex Micro ELISA System

Rainbach im Muehlkreis, Austria

GENSPEED Biotech GmbH – Rapid Multiplex Diagnostics in Laboratory Quality GENSPEED Biotech develops and manufactures rapid diagnostic tests that combine laboratory accuracy with true point-of-care convenience . Our proprietary GENSPEED® Multiplex Micro-ELISA Platform delivers quantitative, lab-quality results within 15–20 minutes from a single drop of capillary blood or other biological samples. The technology integrates microfluidics, chemiluminescence detection, and multiplexed ELISA chemistry in a compact, cartridge-based format. It enables simultaneous quantification of up to eight biomarkers, providing comprehensive diagnostic insights directly at the point of need — in pharmacies, doctors offices, clinics, and research laboratories. GENSPEED is IVDR-certified and already offers CE-marked assays such as the Vitamin D xPOC , FSME (TBE) IgG xPOC , COVID-19 IgG xPOC , and PerioPOC Pro tests. Current developments include multiplex assays for prosthetic joint infection (PJI) , process analytical testing for biopharmaceutical manufacturing (HEK293 HCP assay) and other applications. Our vision is to bring laboratory diagnostics to the point of care – enabling faster, data-driven medical decisions that improve patient outcomes and strengthen healthcare accessibility.